Mizuho Medy Co Ltd
Mizuho Medy maintains a strong liquidity position, with cash and equivalents amounting to ¥10.83 billion, representing nearly half of its total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The current ratio of 7.36 suggests robust short-term liquidity, well above the industry median for medical equipment and distribution firms. Profitability metrics for Mizuho Medy are strong, with a return on equity (ROE) of 18.34% and a return on assets (ROA) of 15.31%. These figures exceed the industry median for ROE and ROA in the medical equipment and distribution sector, indicating efficient use of equity and assets to generate returns. The company's revenue is concentrated in its core medical equipment and supplies business, with no disclosed geographic diversification in the provided data. This suggests a high degree of revenue concentration in its primary business segment, which may expose the company to sector-specific risks. Mizuho Medy's growth trajectory appears stable, with no significant revenue growth or decline reported in the latest financial data. The company's operating cash flow of ¥1.96 billion and free cash flow of ¥1.33 billion support its operational flexibility and capacity for reinvestment. Analysts have assigned a neutral recommendation, with a mean price target of ¥1,850 and a single "hold" rating. Risk factors for Mizuho Medy are currently low, with no immediate liquidity or dilution flags detected. The company has no long-term debt and a low dilution risk, as shares outstanding remain unchanged between basic and diluted counts. No recent filings or transcripts indicate material risk events or strategic shifts. Recent analyst estimates reflect a neutral outlook, with a mean recommendation of 3.00 (on a 1-5 scale) and a single "hold" rating. The lack of strong buy or buy ratings suggests limited upside potential in the near term, though the company's strong liquidity and profitability position it well for long-term stability.
Business. Mizuho Medy Co Ltd provides medical equipment, supplies, and distribution services in the healthcare sector, generating revenue primarily through the sale and distribution of medical devices and related products.
Classification. Mizuho Medy is classified under the Healthcare Services & Equipment business sector and the Medical Equipment, Supplies & Distribution industry, with a classification confidence of 0.92.
- Mizuho Medy has a strong liquidity position with ¥10.83 billion in cash and equivalents and no long-term debt.
- The company's ROE of 18.34% and ROA of 15.31% exceed industry medians, indicating strong profitability.
- Revenue is concentrated in the core medical equipment and supplies business, with no geographic diversification disclosed.
- Analysts have assigned a neutral outlook, with a mean price target of ¥1,850 and a single "hold" rating.
- No immediate liquidity or dilution risks are present, and the company's capital structure is conservative.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.